Updates and Information on Coronavirus (COVID-19)
Skip to content Skip to main navigation Report an accessibility issue

COVID-19 Funding Opportunities

Information about funding opportunities related to the novel coronavirus (COVID-19) will be added to this page as they become available. Please contact the Associate Vice Chancellor for Research Development (avcrd@utk.edu) for more information or to report additional opportunities.

 

Deadline

Title

Funding Agency

More Information

Continuous submission Artist Relief Americans for the Arts
1/31/21 COVID-19 Vaccine: Safety and Immunization Monitoring Asian Development Bank (ADB)
Open COVID-19 Collective Fund for Trans Communities Borealis Philanthropy
1/13/21 Broad Agency Announcement CDC
Open Rapid Development of Vaccines Against COVID-19 Coalition for Epidemic Preparedness Initiative (CEPI)
Open Innovation Fund Comcast
Continuous Submission Public Works and Economic Adjustment Assistance Programs DOC
Continuous Submission Dear Colleague Letter–Coronavirus Disease 2019 (COVID-19) DOE
Rolling Invitation for COVID-19 Scientific Questions DOE
Continuous Submission The COVID-19 High Performance Computing Consortium DOE
Rapid COVID-19 Research at the Spallation Neutron Source and High Flux Isotope Reactor DOE
1/19/21 Grand Challenges ICODA COVID-19 Data Science Grant Programme Gates Foundation Please contact Sally Morris at smorri41@utk.edu if you’re interested in applying.
Open COVID-19 Open Research Dataset Challenge (CORD-19) Kaggle
Rolling COVID-19 Emergency Fund for Journalists National Geographic Society
Rolling Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) NIH
1/16/21 NOSI: Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts NIH / NGHRI
6/12/21 Emergency Awards: NOSI on Pan-Coronavirus Vaccine Development Program Projects NIH / NIAID
9/8/24 NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection NIH / NIDA
3/17/21 NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NIH / NCATS
5/8/23 NOSI: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic NIH / NICHD
4/1/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NIH / OBSSR
4/15/21 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NIH / NINDS
4/16/21 NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NIH / NIAAA
4/16/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NIH / NIMH
7/16/23 NOSI: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract NIH / NICHD
5/1/21 NOSI: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NIH / NIMHD
3/17/21 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) NIH
5/4/21 NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NIH / NIEHS
3/31/21 NOSI: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NIH / NIBIB
2/5/21 NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NIH / NIGMS
3/25/21 NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
Check with PO Administrative Supplements to Existing NIH Grants and Cooperative Agreements; No limit to funding NIH
3/31/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NIH / NIDA
5/1/21 NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NIA
9/8/22 NOSI: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders NIH / NIDCD
7/2/21 NOSI regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
7/10/21 NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NIH
9/1/21 NOSI: Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 NIH / NIAID
Continuous Submission Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) NIH/DHHS
N/A Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations OMB
N/A Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset Office of Science and Technology Policy
Continuous Direct COVID-19 Response – Charitable Grant Open Road Alliance
Rolling Pioneering Ideas: Exploring the Future to Build a Culture of Health Robert Wood Johnson Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.

 

Other Resources

Ubermedia: COVID-19 Impact Research Resources